{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:19:27Z","timestamp":1783019967994,"version":"3.54.6"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010254","name":"Kent State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ymthe.2021.05.013","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:23:40Z","timestamp":1620944620000},"page":"831-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter"],"prefix":"10.1016","volume":"30","author":[{"given":"Nathan","family":"Beals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Farhath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brintha","family":"Croos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thulasi","family":"Mahendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.05.013_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00018-007-6362-1","article-title":"Enzymatic hydroxylation of aromatic compounds","volume":"64","author":"Ullrich","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2021.05.013_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.bi.40.070171.002341","article-title":"Biochemistry of catecholamines","volume":"40","author":"Molinoff","year":"1971","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2021.05.013_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.neuropharm.2009.07.026","article-title":"Neurobiology of ADHD","volume":"57","author":"Tripp","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymthe.2021.05.013_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/026988119701100208","article-title":"Catecholamine regulation of the prefrontal cortex","volume":"11","author":"Arnsten","year":"1997","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neubiorev.2008.10.010","article-title":"Dopamine modulates neural networks involved in effort-based decision-making","volume":"33","author":"Assadi","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymthe.2021.05.013_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1749-6632.1986.tb14630.x","article-title":"Behavioral and neurochemical consequences associated with stressors","volume":"467","author":"Anisman","year":"1986","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ymthe.2021.05.013_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.biopsych.2005.12.017","article-title":"Imaging in Parkinson\u2019s disease: the role of monoamines in behavior","volume":"59","author":"Brooks","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ymthe.2021.05.013_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymthe.2021.05.013_bib9","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1038\/ncomms6769","article-title":"Regulation of tyrosine hydroxylase transcription by hnRNP K and DNA secondary structure","volume":"5","author":"Banerjee","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.05.013_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson\u2019s disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JPD-2011-11046","article-title":"Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson\u2019s disease","volume":"1","author":"Parkkinen","year":"2011","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.ymthe.2021.05.013_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187152712800792785","article-title":"A synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease","volume":"11","author":"Tabrez","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ymthe.2021.05.013_bib13","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1021\/acs.biochem.5b00209","article-title":"G-Quadruplex-Enabling Sequence within the Human Tyrosine Hydroxylase Promoter Differentially Regulates Transcription","volume":"54","author":"Farhath","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2021.05.013_bib14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0092-8674(89)90610-7","article-title":"Monovalent cation-induced structure of telomeric DNA: the G-quartet model","volume":"59","author":"Williamson","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.05.013_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4155\/fmc.09.172","article-title":"Structural insights into G-quadruplexes: towards new anticancer drugs","volume":"2","author":"Yang","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ymthe.2021.05.013_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biochi.2008.02.020","article-title":"Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions","volume":"90","author":"Qin","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.ymthe.2021.05.013_bib17","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1093\/nar\/gkm538","article-title":"Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4","volume":"35","author":"Qin","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib18","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1093\/nar\/gki917","article-title":"Facilitation of a structural transition in the polypurine\/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents","volume":"33","author":"Sun","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib19","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1093\/nar\/gkn380","article-title":"Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene","volume":"36","author":"Guo","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib20","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1073\/pnas.182256799","article-title":"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription","volume":"99","author":"Siddiqui-Jain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.05.013_bib21","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1093\/nar\/gkn120","article-title":"Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins","volume":"36","author":"Cogoi","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib22","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1021\/ja0563861","article-title":"Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter","volume":"128","author":"Dexheimer","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2021.05.013_bib23","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1093\/nar\/gkl610","article-title":"NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region","volume":"34","author":"Dai","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib24","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1093\/nar\/gkm711","article-title":"Human telomere, oncogenic promoter and 5\u2032-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics","volume":"35","author":"Patel","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd3428","article-title":"Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?","volume":"10","author":"Balasubramanian","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2021.05.013_bib26","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/acs.jmedchem.5b01835","article-title":"Quadruplex Nucleic Acids as Novel Therapeutic Targets","volume":"59","author":"Neidle","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2021.05.013_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2021.05.013_bib28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1126\/science.1125559","article-title":"Oligonucleotide-modified gold nanoparticles for intracellular gene regulation","volume":"312","author":"Rosi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.05.013_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2021.05.013_bib30","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/nprot.2007.380","article-title":"DMS footprinting of structured RNAs and RNA-protein complexes","volume":"2","author":"Tijerina","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.05.013_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fchem.2016.00038","article-title":"Metal Cations in G-Quadruplex Folding and Stability","volume":"4","author":"Bhattacharyya","year":"2016","journal-title":"Front Chem."},{"key":"10.1016\/j.ymthe.2021.05.013_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: from concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.ymthe.2021.05.013_bib33","first-page":"3475","article-title":"Peptide-mediated targeting of liposomes to TrkB receptor-expressing cells","volume":"7","author":"Ranjan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2021.05.013_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2021.05.013_bib35","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1038\/mtna.2013.71","article-title":"Two interconvertible folds modulate the activity of a DNA aptamer against transferrin receptor","volume":"3","author":"Porciani","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.05.013_bib36","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/smll.201100628","article-title":"Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?","volume":"7","author":"Cheng","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.ymthe.2021.05.013_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in\u00a0vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ymthe.2021.05.013_bib38","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/s41467-018-04691-x","article-title":"Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines","volume":"9","author":"Porciani","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.05.013_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","article-title":"Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles","volume":"13","author":"Foroozandeh","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ymthe.2021.05.013_bib40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2021.05.013_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib42","doi-asserted-by":"crossref","first-page":"e113151","DOI":"10.1371\/journal.pone.0113151","article-title":"The hTH-GFP reporter rat model for the study of Parkinson\u2019s disease","volume":"9","author":"Iacovitti","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.05.013_bib43","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1021\/jm970199z","article-title":"Inhibition of human telomerase by a G-quadruplex-interactive compound","volume":"40","author":"Sun","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2021.05.013_bib44","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1039\/c0cs00134a","article-title":"Chemistry in human telomere biology: structure, function and targeting of telomere DNA\/RNA","volume":"40","author":"Xu","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ymthe.2021.05.013_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nchembio.780","article-title":"Small-molecule-induced DNA damage identifies alternative DNA structures in human genes","volume":"8","author":"Rodriguez","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biochi.2007.07.011","article-title":"Targeting telomeres and telomerase","volume":"90","author":"De Cian","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.ymthe.2021.05.013_bib47","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1093\/nar\/gkp181","article-title":"Direct experimental evidence for quadruplex-quadruplex interaction within the human ILPR","volume":"37","author":"Schonhoft","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib48","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1021\/ja056097c","article-title":"Insulin capture by an insulin-linked polymorphic region G-quadruplex DNA oligonucleotide","volume":"128","author":"Connor","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2021.05.013_bib49","doi-asserted-by":"crossref","first-page":"160022","DOI":"10.1098\/rsob.160022","article-title":"Constitutive translation of human \u03b1-synuclein is mediated by the 5\u2032-untranslated region","volume":"6","author":"Koukouraki","year":"2016","journal-title":"Open Biol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15252\/emmm.201707850","article-title":"G-quadruplex-binding small molecules ameliorate C9orf72 FTD\/ALS pathology in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Simone","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2021.05.013_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12265-011-9258-2","article-title":"G-quadruplexes-novel mediators of gene function","volume":"4","author":"Zhou","year":"2011","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14728222.2011.556621","article-title":"Telomeres as targets for anticancer therapies","volume":"15","author":"Folini","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ymthe.2021.05.013_bib53","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1039\/c1cs15067g","article-title":"The application of DNA and RNA G-quadruplexes to therapeutic medicines","volume":"40","author":"Collie","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ymthe.2021.05.013_bib54","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1093\/nar\/gkaa186","article-title":"Selective targeting of mutually exclusive DNA G-quadruplexes: HIV-1 LTR as paradigmatic model","volume":"48","author":"Tassinari","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib55","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acschembio.7b00749","article-title":"Targeting of G-Quadruplex Harboring Pre-miRNA 92b by LNA Rescues PTEN Expression in NSCL Cancer Cells","volume":"13","author":"Mirihana Arachchilage","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib56","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1021\/bi5008904","article-title":"Rationally induced RNA:DNA G-quadruplex structures elicit an anticancer effect by inhibiting endogenous eIF-4E expression","volume":"53","author":"Bhattacharyya","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2021.05.013_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jps.22243","article-title":"Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics","volume":"100","author":"Xu","year":"2011","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2021.05.013_bib58","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/nn501292z","article-title":"Precision nanomedicine in neurodegenerative diseases","volume":"8","author":"Goldsmith","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2021.05.013_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer\u2019s disease","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2021.05.013_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","article-title":"Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson\u2019s disease following intranasal administration","volume":"151","author":"Wen","year":"2011","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2021.05.013_bib61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","article-title":"Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce \u03b1-Synuclein Expression in a Model of Parkinson\u2019s Disease","volume":"9","author":"Helmschrodt","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.05.013_bib62","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2021.05.013_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2010.0264","article-title":"Cell-specific aptamer-mediated targeted drug delivery","volume":"21","author":"Zhou","year":"2011","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.ymthe.2021.05.013_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib65","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1083\/jcb.95.2.676","article-title":"Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts","volume":"95","author":"Maxfield","year":"1982","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2021.05.013_bib66","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.biotechadv.2015.05.005","article-title":"A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin","volume":"33","author":"Hou","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ymthe.2021.05.013_bib67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1602\/neurorx.2.1.129","article-title":"Tyrosine hydroxylase replacement in experimental Parkinson\u2019s disease with transvascular gene therapy","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ymthe.2021.05.013_bib68","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/104303404322959498","article-title":"Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter","volume":"15","author":"Zhang","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2021.05.013_bib69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2021.05.013_bib70","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2021.05.013_bib71","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1021\/acsomega.7b01168","article-title":"Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells","volume":"2","author":"Beals","year":"2017","journal-title":"ACS Omega"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621002653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621002653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:48:23Z","timestamp":1777618103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621002653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1525001621002653"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.05.013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021","name":"copyright","label":"Copyright"}]}}